Is it time to prescribe statins to patients with calcified aortic stenosis? - 21/08/11
Doi : 10.1016/j.ahj.2005.01.021
Arash Rashidi, MD a, ⁎ 
, Dale S. Adler, MD b, Ward Casscells, MD c, d, Mohammad Madjid, MD c, d
, Dale S. Adler, MD b, Ward Casscells, MD c, d, Mohammad Madjid, MD c, d a Fairview Hospital, Cleveland Clinic Health System, Cleveland, Ohio
b Case Western Reserve University, University Hospitals of Cleveland, Cleveland, Ohio
c Texas Heart Institute, Houston, Tex
d The University of Texas Health Science Center at Houston, Houston, Tex
⁎Reprint requests: Arash Rashidi, MD, Fairview Hospital, Cleveland Clinic Health System, 18101 Lorain Ave, Cleveland, Ohio 44111.
Résumé |
Aortic stenosis (AS) is a common disease especially in the older population. It is associated with high mortality and morbidity. Recent data suggest that coronary artery disease and AS share common risk factors. Retrospective studies suggest that statins might slow the progression of AS but there are no randomized clinical trial data available. It would seem that statins can be considered for medical treatment of AS; however, this needs to be investigated in future randomized clinical trials.
Le texte complet de cet article est disponible en PDF.Plan
© 2005
Mosby, Inc. Tous droits réservés.
Vol 150 - N° 1
P. 41-45 - juillet 2005 Retour au numéro
Article précédent
- Management of risk in peripheral artery disease: Recent therapeutic advances
- Daniel G. Hackam, Shaun G. Goodman, Sonia S. Anand
- Tezosentan in patients with acute heart failure: Design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS)
- John R. Teerlink, John J.V. McMurray, Robert C. Bourge, John G.F. Cleland, Gadi Cotter, Guillaume Jondeau, Henry Krum, Marco Metra, Christopher M. O'Connor, John D. Parker, Guillermo Torre-Amione, Dirk J. Van Veldhuisen, Aline Frey, Maurizio Rainisio, Isaac Kobrin, VERITAS Investigators
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?